Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 06:30 am Sale | 13G | TALARIS THERAPEUTICS INC TALS | CITADEL ADVISORS LLC | 3,811,639 9% | -2,220 (-0.06%) | View |
2022-02-11 4:24 pm Purchase | 13G | TALARIS THERAPEUTICS INC TALS | Blackstone Holdings II L.P. | 8,089,315 19.6% | 8,089,315 (New Position) | View |
2022-02-04 4:12 pm Purchase | 13G | TALARIS THERAPEUTICS INC TALS | BlackRock Inc. BLK | 2,395,465 5.8% | 2,395,465 (New Position) | View |
2021-05-21 4:28 pm Purchase | 13D | TALARIS THERAPEUTICS INC TALS | Longitude Capital Partners III LLC | 3,220,775 7.8% | 3,220,775 (New Position) | View |
2021-05-21 4:08 pm Purchase | 13G | TALARIS THERAPEUTICS INC TALS | CITADEL ADVISORS LLC | 3,813,859 9.2% | 3,813,859 (New Position) | View |
2021-05-17 1:25 pm Purchase | 13G | TALARIS THERAPEUTICS INC TALS | VIKING GLOBAL INVESTORS LP | 3,289,617 8.2% | 3,289,617 (New Position) | View |